Stocklytics score rationale: value 14, quality 68, growth 43.
Financials
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
1509100000
1600200000
1718000000
1843600000
2146699999
2830700000
2885500000
2951100000
2892700000
3073700000
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and…
Forecast
Consensus Buy from 18 analysts. Average price target $419.50, -3.5% versus the current price. Low $390.00. High $447.00.
Analysts have an average 12-month price target of $419.50 for West Pharmaceutical Services (WST), 3.8% below the current price of $436.11. Of 18 analysts covering the stock, 16 rate it Buy or Strong Buy, 1 Hold, and 1 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
WST price target
12-month price target
Low
$390.00
Average
$419.50
High
$447.00
The average is 3.8% below the current price of $436.11.
Is West Pharmaceutical Services a buy or sell?
Of 18 analysts, 16 rate West Pharmaceutical Services Buy or Strong Buy, 1 Hold, and 1 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
West Pharmaceutical Services earnings and revenue forecast
The Stocklytics Score for WST is 42 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
WST forecast FAQs
What is the WST price target?
$419.50 average, with a published range of $390.00 to $447.00.
Is West Pharmaceutical Services a buy or sell?
The consensus is Buy from 18 analysts. This is not a recommendation.
What is the West Pharmaceutical Services stock forecast for 2026?
Analysts' average EPS estimate for 2026 on file is $8.98. The average revenue estimate is $3.38 billion.
What will WST be worth in 2030?
No reliable forecast exists that far out.
When is West Pharmaceutical Services's next earnings report?
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.